Lista de obras -

A Behavioral and Cognitive Profile of Clinically Stable HIV-Infected Children

article

A Pediatric Infectious Disease Perspective of SARS-CoV-2 and COVID-19 in Children

artículo científico publicado en 2020

Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children

artículo científico publicado en 2010

Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy

artículo científico publicado en 2013

Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy

artículo científico publicado en 2005

Assessing Psychiatric Symptoms in Youth Affected by HIV: Comparing a Brief Self-Administered Rating Scale with a Structured Diagnostic Interview

artículo científico publicado en 2018

Baseline resistance to nucleoside reverse transcriptase inhibitors fails to predict virologic response to combination therapy in children (PACTG 338).

artículo científico publicado en 2007

COVID-19 pharmacologic treatments for children: research priorities and approach to pediatric studies

artículo científico publicado en 2020

CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children.

artículo científico publicado en 2007

CYP2C19 genetic variants affect nelfinavir pharmacokinetics and virologic response in HIV-1-infected children receiving highly active antiretroviral therapy

artículo científico publicado en 2010

Central Nervous System Vasculopathy in HIV-Infected Children Enrolled in the Pediatric AIDS Clinical Trials Group 219/219C Study

artículo científico publicado en 2012

Characterization of functional antibody and memory B-cell responses to pH1N1 monovalent vaccine in HIV-infected children and youth

artículo científico publicado en 2015

Co-occuring psychiatric symptoms in children perinatally infected with HIV and peer comparison sample

artículo científico publicado en 2010

Combination Nucleoside Analog Reverse Transcriptase Inhibitor(s) Plus Nevirapine, Nelfinavir, or Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children: Week 24 Results of a Randomized Controlled Trial - PACTG 377

article

Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.

artículo científico publicado en 2017

Decreased PD-1 Expression on CD8 Lymphocyte Subsets and Increase in CD8 Tscm Cells in Children with HIV Receiving Raltegravir

artículo científico publicado en 2016

Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine

artículo científico publicado en 2015

Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study

artículo científico publicado en 2011

Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants

artículo científico publicado en 2010

Efficacy, tolerability and pharmacokinetics of two nelfinavir-based regimens in human immunodeficiency virus-infected children and adolescents: pediatric AIDS clinical trials group protocol 403.

artículo científico publicado en 2005

Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel.

artículo científico publicado en 2012

Executive Summary: Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children: Recommendations From the National Institutes of Health, the Centers for Disease Control and Prevention, the HIV Medi

artículo científico publicado en 2013

Executive summary: 2013 update of the guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children

artículo científico publicado en 2013

Family Contextual Factors are Differentially Associated with Depressive Symptoms among Boys and Girls with Perinatally Acquired HIV

scientific article published on 08 July 2020

Genomic analysis of HIV type 1 strains derived from a mother and child pair of long-term nonprogressors

artículo científico publicado en 2007

Growth in human immunodeficiency virus-infected children receiving ritonavir-containing antiretroviral therapy

artículo científico publicado en 2002

Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy

artículo científico publicado en 2005

Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the

artículo científico publicado en 2013

H1N1 influenza vaccination in HIV-infected women on effective antiretroviral treatment did not induce measurable antigen-driven proliferation of the HIV-1 proviral reservoir

scientific article published on 13 February 2017

Heterogeneity of T Cell Responses to Pandemic pH1N1 Monovalent Vaccine in HIV-Infected Pregnant Women

artículo científico publicado en 2015

High Incidence of Tuberculosis Infection in HIV-Exposed Children Exiting an Isoniazid Preventive Therapy Trial

artículo científico publicado en 2018

High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088) ⬇️

artículo científico publicado el 31 de enero de 2013

Human Immunodeficiency Virus Disease Severity, Psychiatric Symptoms, and Functional Outcomes in Perinatally Infected Youth ⬇️

artículo científico publicado el 1 de junio de 2012

Immunogenicity and Safety of 1 vs 2 Doses of Quadrivalent Meningococcal Conjugate Vaccine in Youth Infected with Human Immunodeficiency Virus ⬇️

artículo científico publicado el 22 de mayo de 2012

Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy

artículo científico publicado en 2009

Immunogenicity of Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-Infected Children and Youth.

artículo científico publicado en 2013

Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy

artículo científico publicado en 2012

Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy

artículo científico publicado en 2006

Immunologic response to combination nucleoside analogue plus protease inhibitor therapy in stable antiretroviral therapy-experienced human immunodeficiency virus-infected children

artículo científico publicado en 2000

Immunological response to highly active antiretroviral therapy in children with clinically stable HIV-1 infection

artículo científico publicado en 2005

Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era.

artículo científico publicado en 2009

Incidence of opportunistic and other infections in HIV-infected children in the HAART era.

artículo científico

Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps and research priorities

scientific article published on 12 July 2019

Longitudinal Study of Emerging Mental Health Concerns in Youth Perinatally Infected With HIV and Peer Comparisons ⬇️

artículo científico publicado el 1 de julio de 2012

Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022.

artículo científico publicado en 2004

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

artículo científico publicado en 2019

Mental health treatment patterns in perinatally HIV-infected youth and controls

artículo científico publicado en 2009

Model-Based Methods to Translate Adolescent Medicine Trials Network for HIV/AIDS Interventions Findings Into Policy Recommendations: Rationale and Protocol for a Modeling Core (ATN 161)

article

Monitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure

artículo científico publicado en 2012

Mother-to-child transmission in the United States of subtypes D and A/G human immunodeficiency virus type 1.

artículo científico publicado en 2002

Nelfinavir pharmacokinetics in stable human immunodeficiency virus-positive children: Pediatric AIDS Clinical Trials Group Protocol 377.

artículo científico publicado en 2003

Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children.

artículo científico publicado en 2005

Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team

artículo científico publicado en 2000

Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1.

artículo científico publicado en 2002

Participation and retention of youth with perinatal HIV infection in mental health research studies: the IMPAACT P1055 psychiatric comorbidity study

artículo científico publicado en 2013

Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy

artículo científico publicado en 2007

Pharmacokinetic characteristics of ritonavir, zidovudine, lamivudine, and stavudine in children with human immunodeficiency virus infection

artículo científico publicado en 2004

Pharmacokinetics and 48-Week Safety and Efficacy of Raltegravir for Oral Suspension in Human Immunodeficiency Virus Type-1-Infected Children 4 Weeks to 2 Years of Age

artículo científico publicado en 2015

Pharmacokinetics and distribution of linezolid in cerebrospinal fluid in children and adolescents

artículo científico publicado en 2010

Pharmacokinetics, safety, and 48-week efficacy of oral raltegravir in HIV-1-infected children aged 2 through 18 years

artículo científico publicado en 2013

Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents

artículo científico publicado en 2010

Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV-infected children 4 weeks to 18 years of age

artículo científico publicado en 2015

Prevalence of pain and association with psychiatric symptom severity in perinatally HIV-infected children as compared to controls living in HIV-affected households

artículo científico publicado en 2010

Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children

artículo científico publicado en 2011

Profiles of caregiving behaviors among children and adolescents with perinatally acquired HIV

scientific article published on 07 February 2019

Psychiatric hospitalizations among children and youths with human immunodeficiency virus infection

artículo científico publicado en 2004

Psychiatric symptoms and antiretroviral nonadherence in US youth with perinatal HIV: a longitudinal study

artículo científico publicado en 2015

Relative bioavailability of bedaquiline tablets suspended in water: Implications for dosing in children

scholarly article by Elin M Svensson et al published 27 June 2018 in British Journal of Clinical Pharmacology

Reply to Holm et al

scientific article published on 13 December 2012

Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection

artículo científico publicado en 2002

Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy

artículo científico publicado en 2006

Safety and Immunogenicity of 2009 Pandemic H1N1 Influenza Vaccination in Perinatally HIV-1-Infected Children, Adolescents, and Young Adults ⬇️

artículo científico publicado el 21 de mayo de 2012

Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial

artículo científico publicado en 2018

Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women

artículo científico publicado en 2013

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection

artículo científico publicado en 2003

Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected children

artículo científico publicado en 2012

Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer ⬇️

artículo científico publicado el 13 de abril de 2011

Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children

artículo científico publicado en 2008

Single-dose pharmacokinetics of enteric-coated didanosine in HIV-infected children.

artículo científico publicado en 2002

Stavudine, nevirapine and ritonavir in stable antiretroviral therapy-experienced children with human immunodeficiency virus infection

artículo científico publicado en 2002

Substance use and its association with psychiatric symptoms in perinatally HIV-infected and HIV-affected adolescents

artículo científico publicado en 2010

Switch from ritonavir to indinavir in combination therapy for HIV-1-infected children

artículo científico publicado en 2005

T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines

artículo científico publicado en 2010

Tetanus immunity after diphtheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infection

scientific article published on 01 September 2005

The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life

artículo científico publicado en 2014

The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis

artículo científico publicado en 2005

Towards early inclusion of children in tuberculosis drugs trials: a consensus statement

artículo científico publicado en 2015

Virologic and immunologic correlates with the magnitude of antibody responses to the hepatitis A vaccine in HIV-infected children on highly active antiretroviral treatment

artículo científico publicado en 2009

Lista de obras de

A Behavioral and Cognitive Profile of Clinically Stable HIV-Infected Children

A Pediatric Infectious Disease Perspective of SARS-CoV-2 and COVID-19 in Children

Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children

Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy

Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy

Assessing Psychiatric Symptoms in Youth Affected by HIV: Comparing a Brief Self-Administered Rating Scale with a Structured Diagnostic Interview

Baseline resistance to nucleoside reverse transcriptase inhibitors fails to predict virologic response to combination therapy in children (PACTG 338).

COVID-19 pharmacologic treatments for children: research priorities and approach to pediatric studies

CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children.

CYP2C19 genetic variants affect nelfinavir pharmacokinetics and virologic response in HIV-1-infected children receiving highly active antiretroviral therapy

Central Nervous System Vasculopathy in HIV-Infected Children Enrolled in the Pediatric AIDS Clinical Trials Group 219/219C Study

Characterization of functional antibody and memory B-cell responses to pH1N1 monovalent vaccine in HIV-infected children and youth

Co-occuring psychiatric symptoms in children perinatally infected with HIV and peer comparison sample

Combination Nucleoside Analog Reverse Transcriptase Inhibitor(s) Plus Nevirapine, Nelfinavir, or Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children: Week 24 Results of a Randomized Controlled Trial - PACTG 377

Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.

Decreased PD-1 Expression on CD8 Lymphocyte Subsets and Increase in CD8 Tscm Cells in Children with HIV Receiving Raltegravir

Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine

Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study

Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants

Efficacy, tolerability and pharmacokinetics of two nelfinavir-based regimens in human immunodeficiency virus-infected children and adolescents: pediatric AIDS clinical trials group protocol 403.

Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel.

Executive Summary: Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children: Recommendations From the National Institutes of Health, the Centers for Disease Control and Prevention, the HIV Medi

Executive summary: 2013 update of the guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children

Family Contextual Factors are Differentially Associated with Depressive Symptoms among Boys and Girls with Perinatally Acquired HIV

Genomic analysis of HIV type 1 strains derived from a mother and child pair of long-term nonprogressors

Growth in human immunodeficiency virus-infected children receiving ritonavir-containing antiretroviral therapy

Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy

Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the

H1N1 influenza vaccination in HIV-infected women on effective antiretroviral treatment did not induce measurable antigen-driven proliferation of the HIV-1 proviral reservoir

Heterogeneity of T Cell Responses to Pandemic pH1N1 Monovalent Vaccine in HIV-Infected Pregnant Women

High Incidence of Tuberculosis Infection in HIV-Exposed Children Exiting an Isoniazid Preventive Therapy Trial

High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088) ⬇️

Human Immunodeficiency Virus Disease Severity, Psychiatric Symptoms, and Functional Outcomes in Perinatally Infected Youth ⬇️

Immunogenicity and Safety of 1 vs 2 Doses of Quadrivalent Meningococcal Conjugate Vaccine in Youth Infected with Human Immunodeficiency Virus ⬇️

Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy

Immunogenicity of Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-Infected Children and Youth.

Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy

Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy

Immunologic response to combination nucleoside analogue plus protease inhibitor therapy in stable antiretroviral therapy-experienced human immunodeficiency virus-infected children

Immunological response to highly active antiretroviral therapy in children with clinically stable HIV-1 infection

Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era.

Incidence of opportunistic and other infections in HIV-infected children in the HAART era.

Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps and research priorities

Longitudinal Study of Emerging Mental Health Concerns in Youth Perinatally Infected With HIV and Peer Comparisons ⬇️

Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022.

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

Mental health treatment patterns in perinatally HIV-infected youth and controls

Model-Based Methods to Translate Adolescent Medicine Trials Network for HIV/AIDS Interventions Findings Into Policy Recommendations: Rationale and Protocol for a Modeling Core (ATN 161)

Monitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure

Mother-to-child transmission in the United States of subtypes D and A/G human immunodeficiency virus type 1.

Nelfinavir pharmacokinetics in stable human immunodeficiency virus-positive children: Pediatric AIDS Clinical Trials Group Protocol 377.

Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children.

Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team

Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1.

Participation and retention of youth with perinatal HIV infection in mental health research studies: the IMPAACT P1055 psychiatric comorbidity study

Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy

Pharmacokinetic characteristics of ritonavir, zidovudine, lamivudine, and stavudine in children with human immunodeficiency virus infection

Pharmacokinetics and 48-Week Safety and Efficacy of Raltegravir for Oral Suspension in Human Immunodeficiency Virus Type-1-Infected Children 4 Weeks to 2 Years of Age

Pharmacokinetics and distribution of linezolid in cerebrospinal fluid in children and adolescents

Pharmacokinetics, safety, and 48-week efficacy of oral raltegravir in HIV-1-infected children aged 2 through 18 years

Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents

Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV-infected children 4 weeks to 18 years of age

Prevalence of pain and association with psychiatric symptom severity in perinatally HIV-infected children as compared to controls living in HIV-affected households

Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children

Profiles of caregiving behaviors among children and adolescents with perinatally acquired HIV

Psychiatric hospitalizations among children and youths with human immunodeficiency virus infection

Psychiatric symptoms and antiretroviral nonadherence in US youth with perinatal HIV: a longitudinal study

Relative bioavailability of bedaquiline tablets suspended in water: Implications for dosing in children

Reply to Holm et al

Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection

Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy

Safety and Immunogenicity of 2009 Pandemic H1N1 Influenza Vaccination in Perinatally HIV-1-Infected Children, Adolescents, and Young Adults ⬇️

Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial

Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection

Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected children

Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer ⬇️

Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children

Single-dose pharmacokinetics of enteric-coated didanosine in HIV-infected children.